A Win For NKGen Biotech Inc.
Mon, May 20, 2024 at 06:45 PM
NKGen Biotech Inc. (NKGN:NASDAQ) rocketted at $1.71, representing a gain of 52.7%. On Mon, May 20, 2024, NKGN:NASDAQ hit a New 2-Week High of $1.71. The stock got featured on our News Catalysts scanner on Mon, May 20, 2024 at 03:05 PM in the 'BIOTECH' category. From Mon, May 06, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Mon, May 20, 2024 at $2.14 with a volume of 33M+.
About NKGen Biotech Inc. (NKGN:NASDAQ)
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat...
Top 10 Gainers:
- Schmitt Industries, Inc. (SMIT:NASDAQ), 117.65%
- MultiMetaVerse Holdings Ltd Ord (MMV:NASDAQ), 114.52%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 90.91%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 80.27%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 74.76%
- Zenvia Inc. (ZENV:NASDAQ), 67.39%
- Scorpius Holdings Inc Com Par $0.0002 (SCPX:NYSEMKT), 54.59%
- NKGen Biotech Inc. (NKGN:NASDAQ), 52.68%
- Unico American Corporation (UNAM:NASDAQ), 50%
- Sphere 3D Corp. (ANY:NASDAQ), 48.54%